{"id":17006,"date":"2026-03-07T10:54:08","date_gmt":"2026-03-07T10:54:08","guid":{"rendered":"https:\/\/www.europesays.com\/cz\/17006\/"},"modified":"2026-03-07T10:54:08","modified_gmt":"2026-03-07T10:54:08","slug":"problem-je-cas-onkolog-popisuje-kdy-prutahy-zpomaluji-lecbu-rakoviny","status":"publish","type":"post","link":"https:\/\/www.europesays.com\/cz\/17006\/","title":{"rendered":"\u201eProbl\u00e9m je \u010das.\u201c Onkolog popisuje, kdy pr\u016ftahy zpomaluj\u00ed l\u00e9\u010dbu rakoviny"},"content":{"rendered":"

V\u00e1\u017en\u00e9 diagn\u00f3zy \u010dasto vy\u017eaduj\u00ed l\u00e9\u010dbu \u0161itou na m\u00edru. U\u00a0slo\u017eit\u00fdch \u010di vz\u00e1cn\u011bj\u0161\u00edch p\u0159\u00edpad\u016f ale \u00fahrada ze zdravotn\u00edho poji\u0161t\u011bn\u00ed neb\u00fdv\u00e1 p\u0159edem jasn\u011b dan\u00e1, a\u00a0l\u00e9ka\u0159i proto mus\u00ed \u017e\u00e1dat o\u00a0mimo\u0159\u00e1dnou \u00fahradu.<\/p>\n

Vy\u0159\u00edzen\u00ed t\u011bchto \u017e\u00e1dost\u00ed ale m\u016f\u017ee b\u00fdt zdlouhav\u00e9 a\u00a0administrativn\u011b n\u00e1ro\u010dn\u00e9. Pokud poji\u0161\u0165ovna po\u017eaduje dopl\u0148uj\u00edc\u00ed dokumenty, rozhodnut\u00ed se protahuje i\u00a0o n\u011bkolik t\u00fddn\u016f\u00a0\u2013 v\u00a0dob\u011b, kdy n\u011bkter\u00fdm pacient\u016fm doch\u00e1z\u00ed \u010das.<\/p>\n

\u201ePokud si poji\u0161\u0165ovna vy\u017e\u00e1d\u00e1 dal\u0161\u00ed dokumenty, jde v\u011bc do spr\u00e1vn\u00edho \u0159\u00edzen\u00ed a\u00a0proces se protahuje na 30\u00a0a\u017e 60\u00a0dn\u00ed. To je probl\u00e9m, proto\u017ee l\u00e9\u010dba u\u00a0onkologick\u00fdch pacient\u016f \u010dasto sp\u011bch\u00e1,\u201c vysv\u011btluje v\u00a0rozhovoru pro Seznam Zpr\u00e1vy profesor onkologie Martin Klabusay.<\/p>\n

Ro\u010dn\u011b stovk\u00e1m \u017eadatel\u016f o\u00a0mimo\u0159\u00e1dn\u00e9 \u00fahrady nav\u00edc doraz\u00ed zam\u00edtav\u00e1 odpov\u011b\u010f. Z\u00a0\u0159\u00e1dov\u011b des\u00edtek tis\u00edc \u017e\u00e1dost\u00ed jde sice o\u00a0malou \u010d\u00e1st p\u0159\u00edpad\u016f, dot\u010den\u00fdm lidem ale na rozhodnut\u00ed \u010dasto z\u00e1vis\u00ed zdrav\u00ed – a\u00a0v u\u017e tak k\u0159ehk\u00e9 situaci to pro n\u011b zpravidla znamen\u00e1 dal\u0161\u00ed psychickou z\u00e1t\u011b\u017e.<\/p>\n

Popsali<\/a> jsme p\u0159\u00edpad pacientky, u\u00a0n\u00ed\u017e multidisciplin\u00e1rn\u00ed t\u00fdm ur\u010dil jedinou mo\u017enou l\u00e9\u010dbu, ale VZP ji odm\u00edtla uhradit. Jak \u010dasto se s\u00a0n\u011b\u010d\u00edm takov\u00fdm setk\u00e1v\u00e1te?<\/p>\n

J\u00e1 jsem se s\u00a0t\u00edmto probl\u00e9mem nesetkal. Jako onkolog p\u00ed\u0161u \u017e\u00e1dosti o\u00a0mimo\u0159\u00e1dnou \u00fahradu na denn\u00ed b\u00e1zi, v\u00a0podstat\u011b ka\u017ed\u00fd druh\u00fd den. Za posledn\u00edch p\u011bt let jsem zaregistroval \u010dty\u0159i zam\u00edtnut\u00e9 \u017e\u00e1dosti, byly ale argumenta\u010dn\u011b i\u00a0odborn\u011b dob\u0159e zpracovan\u00e9.<\/p>\n

\u017d\u00e1dost, pokud je slo\u017eit\u00e1, zpravidla doprov\u00e1z\u00edm pr\u016fvodn\u00edm dopisem na dv\u011b strany, kde vysv\u011btluji sv\u016fj postup a\u00a0n\u00e1zor, pro\u010d by l\u00e9\u010dba m\u011bla b\u00fdt pacientovi uhrazena. Dopl\u0148uji ji odbornou literaturou\u00a0\u2013 jednu, dv\u011b nebo t\u0159i mezin\u00e1rodn\u00ed pr\u00e1ce publikuj\u00edc\u00ed studie k\u00a0dan\u00e9mu l\u00e9ku.<\/p>\n

<\/a><\/p>\n

Tlak na poji\u0161\u0165ovny obecn\u011b roste. Zvy\u0161uje se i\u00a0po\u010det \u017e\u00e1dost\u00ed o\u00a0\u00fahradu mimo\u0159\u00e1dn\u00e9 l\u00e9\u010dby?<\/p>\n

To je komplexn\u00ed probl\u00e9m. V\u011bt\u0161ina l\u00e9k\u016f v\u00a0\u010cesku m\u00e1 svoji \u00fahradu, n\u011bkter\u00e9 speci\u00e1ln\u011bj\u0161\u00ed jsou v\u00e1z\u00e1ny na konkr\u00e9tn\u00ed specializaci l\u00e9ka\u0159e, n\u00e1kladn\u011bj\u0161\u00ed l\u00e9ky na konkr\u00e9tn\u00ed krit\u00e9ria. Ale m\u00e1me diagn\u00f3zy, kter\u00e9 nelze jednozna\u010dn\u011b za\u0161katulkovat\u00a0\u2013 vybo\u010duj\u00ed z\u00a0definice, chovaj\u00ed se jinak, nereaguj\u00ed na l\u00e9\u010dbu nebo jsou velmi vz\u00e1cn\u00e9. A\u00a0u nich l\u00e9\u010dba nen\u00ed jasn\u011b definovan\u00e1. Nav\u00edc nov\u00e9 l\u00e9ky se rychle vyv\u00edjej\u00ed, zhruba ka\u017ed\u00fd t\u0159et\u00ed m\u011bs\u00edc p\u0159ib\u00fdv\u00e1 nov\u00fd prepar\u00e1t. Chv\u00edli trv\u00e1, ne\u017e se za\u0159ad\u00ed do syst\u00e9mu \u00fahrad.<\/p>\n

V t\u011bchto p\u0159\u00edpadech mus\u00edme pod\u00e1vat \u017e\u00e1dost o\u00a0mimo\u0159\u00e1dnou \u00fahradu, takzvanou \u017e\u00e1dost na paragraf 16\u00a0(z\u00e1kona 48\/1997\u00a0Sb., pozn. red.), kdy poji\u0161\u0165ovna hrad\u00ed l\u00e9\u010dbu, pokud je jedinou mo\u017enost\u00ed pro pacienta. Tento syst\u00e9m u\u00a0n\u00e1s funguje \u0159adu let. Po\u010det \u017e\u00e1dost\u00ed se v\u00fdrazn\u011b nezvy\u0161uje, ale je obecn\u011b vysok\u00fd – p\u0159itom by m\u011blo j\u00edt o\u00a0v\u00fdjimky. Bylo by lep\u0161\u00ed, kdyby byl syst\u00e9m m\u00e9n\u011b n\u00e1ro\u010dn\u00fd a\u00a0v\u00edce definoval krit\u00e9ria pro jednozna\u010dnou l\u00e9\u010dbu, aby nebylo nutn\u00e9 tuto instituci pou\u017e\u00edvat tak \u010dasto.<\/p>\n

Jak zlep\u0161it syst\u00e9m<\/p>\n

Ty p\u0159\u00edpady jsou ale \u010dasto velmi specifick\u00e9. Um\u00edte si p\u0159edstavit, co konkr\u00e9tn\u011b by mohlo pomoci?<\/p>\n

Ano, ka\u017ed\u00fd p\u0159\u00edpad je individu\u00e1ln\u00ed, individu\u00e1ln\u011b se mus\u00ed i\u00a0zpracovat a\u00a0posoudit \u017e\u00e1dost. Jeden probl\u00e9m je \u010das. Pod\u00e1n\u00ed \u017e\u00e1dosti zabere ur\u010dit\u00fd \u010das, poji\u0161\u0165ovna m\u00e1 zpravidla dvout\u00fddenn\u00ed lh\u016ftu na zpracov\u00e1n\u00ed, a\u00a0pokud v\u0161e prob\u011bhne hladce, m\u00e1me rozhodnut\u00ed do t\u0159\u00ed t\u00fddn\u016f.<\/p>\n

Pokud si poji\u0161\u0165ovna vy\u017e\u00e1d\u00e1 dal\u0161\u00ed dokumenty, jde v\u011bc do spr\u00e1vn\u00edho \u0159\u00edzen\u00ed a\u00a0proces se protahuje na 30\u00a0a\u017e 60\u00a0dn\u00ed. To je probl\u00e9m, proto\u017ee l\u00e9\u010dba u\u00a0onkologick\u00fdch pacient\u016f \u010dasto sp\u011bch\u00e1. Jednou mo\u017enost\u00ed je tedy zkr\u00e1tit lh\u016fty, aby rozhodnut\u00ed p\u0159i\u0161lo co nejd\u0159\u00edve.<\/p>\n

Druh\u00e1 v\u011bc je sn\u00ed\u017eit po\u010det \u017e\u00e1dost\u00ed obecn\u011b. To by \u0161lo l\u00e9pe definovan\u00fdmi krit\u00e9rii pro \u00fahradu n\u011bkter\u00fdch l\u00e9k\u016f a\u00a0rychlej\u0161\u00edm zpracov\u00e1n\u00edm indikac\u00ed nov\u00fdch prepar\u00e1t\u016f po vstupu na trh. Tak by se sn\u00ed\u017eil po\u010det \u017e\u00e1dost\u00ed o\u00a0mimo\u0159\u00e1dnou \u00fahradu a\u00a0proces by byl celkov\u011b rychlej\u0161\u00ed.<\/p>\n

Podle m\u00fdch zku\u0161enost\u00ed v\u011bt\u0161inou z\u00edsk\u00e1me odpov\u011b\u010f poji\u0161\u0165ovny zhruba do t\u0159\u00ed t\u00fddn\u016f, co\u017e je zpravidla akceptovateln\u00e9. Ve v\u00fdjime\u010dn\u00fdch p\u0159\u00edpadech si poji\u0161\u0165ovna vy\u017e\u00e1d\u00e1 dal\u0161\u00ed dokumenty, a\u00a0proces se pak prot\u00e1hne na m\u011bs\u00edc, v\u00fdjime\u010dn\u011b dva.<\/p>\n

U\u017e jste narazil na to, \u017ee pacient\u016fm ut\u00edk\u00e1 \u010das. N\u011bkte\u0159\u00ed va\u0161i kolegov\u00e9 mluvili o\u00a0tom, \u017ee pr\u016ftahy mohou v\u00a0n\u011bkter\u00fdch p\u0159\u00edpadech sni\u017eovat \u0161anci na vyl\u00e9\u010den\u00ed. Vid\u00edte to stejn\u011b?<\/p>\n

Ne, tak bych to nevid\u011bl. U\u00a0n\u00e1s pacienti dost\u00e1vaj\u00ed tu nejmodern\u011bj\u0161\u00ed l\u00e9\u010dbu, kter\u00e1 je mo\u017en\u00e1. Skute\u010dn\u011b p\u0159ijedu ze sv\u011btov\u00e9ho onkologick\u00e9ho kongresu a\u00a0druh\u00fd den mohu l\u00e9\u010dit podle nejnov\u011bj\u0161\u00edch poznatk\u016f z\u00a0toho kongresu, co\u017e je fantastick\u00e9. A\u00a0to je v\u011bc, kter\u00e1 nen\u00ed v\u0161ude, a\u00a0jist\u011b zejm\u00e9na pacienti, kte\u0159\u00ed maj\u00ed vlastn\u00ed zku\u0161enost se zdravotn\u00ed p\u00e9\u010d\u00ed v\u00a0zahrani\u010d\u00ed, ocen\u00ed, \u017ee n\u00e1\u0161 syst\u00e9m funguje tak, jak funguje.<\/p>\n

N\u00e1klady rostou<\/p>\n

U vyhrocen\u00fdch p\u0159\u00edpad\u016f se objevuje argument, \u017ee n\u011bkterou p\u00e9\u010di jednodu\u0161e necht\u011bj\u00ed propl\u00e1cet, proto\u017ee je moc drah\u00e1. Nar\u00e1\u017e\u00edte na to?<\/p>\n

N\u011bkter\u00e9 modern\u00ed l\u00e9ky zachra\u0148uj\u00ed \u017eivoty, jin\u00e9 pou\u017e\u00edv\u00e1me v\u00a0takzvan\u00fdch paliativn\u00edch indikac\u00edch\u00a0\u2013 jejich c\u00edlem nen\u00ed nemoc vyl\u00e9\u010dit, ale prodlou\u017eit \u017eivot. Nov\u00e9 l\u00e9ky prodlu\u017euj\u00ed \u017eivot v\u00edce ne\u017e star\u00e9, co\u017e je jejich benefit. Jsou ale \u010dasto extr\u00e9mn\u011b komplikovan\u00e9 a\u00a0drah\u00e9. Pou\u017e\u00edv\u00e1me monoklon\u00e1ln\u00ed protil\u00e1tky, c\u00edlen\u00e9 l\u00e9ky proti specifick\u00fdm molekul\u00e1m, konjug\u00e1ty protil\u00e1tek s\u00a0toxiny, bispecifick\u00e9 protil\u00e1tky, genovou a\u00a0bun\u011b\u010dnou terapii. V\u0161echny vy\u017eaduj\u00ed n\u00e1ro\u010dn\u00fd v\u00fdvoj a\u00a0klinick\u00e9 studie k\u00a0ov\u011b\u0159en\u00ed bezpe\u010dnosti a\u00a0\u00fa\u010dinnosti.<\/p>\n

<\/a><\/p>\n

N\u00e1klady na jednoho onkologick\u00e9ho pacienta rostou. Dnes je b\u011b\u017en\u00e9 l\u00e9\u010dit pacienta za milion korun, v\u00fdjime\u010dn\u011b t\u0159i miliony. U\u00a0speci\u00e1ln\u00edch terapi\u00ed jako genov\u00e1 a\u00a0bun\u011b\u010dn\u00e1, mohou n\u00e1klady p\u0159es\u00e1hnout deset milion\u016f. Syst\u00e9m si s\u00a0t\u00edm mus\u00ed poradit\u00a0\u2013 l\u00e9\u010dbu m\u016f\u017eeme hradit jen v\u00a0r\u00e1mci prost\u0159edk\u016f vybran\u00fdch ze zdravotn\u00edho poji\u0161t\u011bn\u00ed.<\/p>\n

D\u00e1m p\u0159\u00edklad: Pokud poji\u0161\u0165ovna p\u0159isp\u00edv\u00e1 90\u00a0korun m\u011bs\u00ed\u010dn\u011b na b\u011b\u017en\u00fd l\u00e9k, kter\u00fd u\u017e\u00edv\u00e1 milion lid\u00ed, stoj\u00ed to zhruba miliardu ro\u010dn\u011b. Za tu samou miliardu m\u016f\u017eeme l\u00e9\u010dit tis\u00edc komplikovan\u00fdch pacient\u016f za milion, nebo sto pacient\u016f genovou terapi\u00ed za deset milion\u016f. Je to ot\u00e1zka nastaven\u00ed syst\u00e9mu a\u00a0velmi k\u0159ehk\u00e9 rovnov\u00e1hy mezi t\u00edm, co chceme hradit a\u00a0jak. N\u00e1\u0161 syst\u00e9m je v\u00a0tom velmi altruistick\u00fd.<\/p>\n

Je to hodn\u011b citliv\u00e9. M\u011bli bychom ale v\u00edc zd\u016fraz\u0148ovat hranici, co jsme je\u0161t\u011b a\u00a0nejsme ochotni platit i\u00a0v takto citliv\u00fdch ot\u00e1zk\u00e1ch?<\/p>\n

Ze sv\u00e9 zku\u0161enosti jsem se nikdy nesetkal s\u00a0ekonomick\u00fdm argumentem ze strany poji\u0161\u0165ovny. I\u00a0u \u017e\u00e1dost\u00ed, kter\u00e9 mi byly zam\u00edtnuty, byla argumentace odborn\u011b velmi dob\u0159e od\u016fvodn\u011bn\u00e1. Nemusel jsem s\u00a0n\u00ed souhlasit, ale byla na vysok\u00e9 \u00farovni\u00a0\u2013 finan\u010dn\u00ed ot\u00e1zka tam nikdy nebyla p\u0159edm\u011btem rozporu.<\/p>\n

Nen\u00ed tedy \u017e\u00e1dn\u00e1 hranice, kdy u\u017e n\u011bco neufinancujeme?<\/p>\n

To bych ne\u0159ekl. N\u00e1\u0161 syst\u00e9m zvl\u00e1d\u00e1 l\u00e9\u010dit na \u00farovni z\u00e1padn\u00ed Evropy, rozd\u00edl nevid\u00edm. Samoz\u0159ejm\u011b se mus\u00edme p\u0159ipravit, \u017ee n\u00e1klady, zejm\u00e9na na l\u00e9\u010dbu onkologick\u00fdch onemocn\u011bn\u00ed, d\u00e1l porostou. Syst\u00e9m se bude muset upravovat a\u00a0kultivovat, aby tyto n\u00e1roky zvl\u00e1dl, ale nehovo\u0159il bych o\u00a0limitov\u00e1n\u00ed n\u00e1klad\u016f na l\u00e9\u010dbu. Naopak bychom m\u011bli um\u011bt uhradit vysoce n\u00e1kladnou l\u00e9\u010dbu u\u00a0p\u0159\u00edpad\u016f vz\u00e1cn\u00fdch diagn\u00f3z.<\/p>\n

Jako p\u0159\u00edklad\u00a0\u2013 v\u00a0\u00fanoru 2022\u00a0byl schv\u00e1len nov\u00fd l\u00e9k pro melanom oka a\u00a0my jsme m\u011bli pacientku u\u017e v\u00a0dubnu. Po t\u0159ech m\u011bs\u00edc\u00edch komunikace s\u00a0poji\u0161\u0165ovnou jsme z\u00edskali \u00fahradu v\u00a0\u010dervnu. L\u00e9\u010dba byla extr\u00e9mn\u011b n\u00e1kladn\u00e1, ale poda\u0159ilo se, a\u00a0dnes je pro ni stanovena standardn\u00ed \u00fahrada. To ukazuje, co lze v\u00a0\u010cesku dok\u00e1zat.<\/p>\n

\u201eM\u016f\u017eeme d\u011blat z\u00e1zraky\u201c<\/p>\n

Je je\u0161t\u011b n\u011bco, co by se mohlo zlep\u0161it, aby byl syst\u00e9m pro v\u0161echny strany uchopiteln\u011bj\u0161\u00ed?<\/p>\n

Jak jsem \u0159\u00edkal, pot\u0159ebovali bychom ps\u00e1t m\u00e9n\u011b \u017e\u00e1dost\u00ed na \u00a7 16\u00a0a\u00a0v\u011bnovat se v\u00edce pacient\u016fm. Jako l\u00e9ka\u0159i bychom uv\u00edtali, a\u00a0pacienti jist\u011b tak\u00e9, kdyby lh\u016fty na zpracov\u00e1n\u00ed \u017e\u00e1dost\u00ed byly co nejkrat\u0161\u00ed a\u00a0krit\u00e9ria pro co nejv\u00edce l\u00e9k\u016f zcela jednozna\u010dn\u00e1, aby nebylo nutn\u00e9 tyto \u017e\u00e1dosti ps\u00e1t. Pr\u016fchodnost \u017e\u00e1dost\u00ed je velmi vysok\u00e1\u00a0\u2013 dle m\u00fdch zku\u0161enost\u00ed p\u0159ibli\u017en\u011b 98\u00a0a\u017e 99\u00a0procent je schv\u00e1leno. Pot\u0159ebujeme ale ulevit administrativ\u011b a\u00a0kultivovat syst\u00e9m, aby jich bylo m\u00e9n\u011b.<\/p>\n

Co byste vzk\u00e1zal pacient\u016fm, aby l\u00e9pe ch\u00e1pali syst\u00e9m a\u00a0limity l\u00e9\u010dby?<\/p>\n

Pacienti by se m\u011bli pt\u00e1t sv\u00e9ho l\u00e9ka\u0159e, sv\u00e9ho onkologa, a\u00a0zji\u0161\u0165ovat mo\u017enosti l\u00e9\u010dby. M\u00e1m r\u00e1d, kdy\u017e je pacient informov\u00e1n, diskutuje se mnou, probereme mo\u017enosti, vysv\u011btl\u00edm, kter\u00e1 je lep\u0161\u00ed a\u00a0kter\u00e1 hor\u0161\u00ed podle m\u00e9ho n\u00e1zoru, a\u00a0spole\u010dn\u011b se dohodneme, jak l\u00e9\u010dbu v\u00e9st. To je v\u017edy nejlep\u0161\u00ed zp\u016fsob pro l\u00e9ka\u0159e i\u00a0pacienta.<\/p>\n

Onkologie za posledn\u00edch 25\u00a0let nesm\u00edrn\u011b pokro\u010dila. Je to jeden z\u00a0nejrychleji se rozv\u00edjej\u00edc\u00edch obor\u016f medic\u00edny. M\u00e1me \u00fa\u017easn\u00e9 mo\u017enosti a\u00a0ve spoust\u011b diagn\u00f3z se zcela zm\u011bnil osud pacient\u016f. Nap\u0159\u00edklad melanom\u00a0\u2013 dnes m\u00e1me imunoterapii, kter\u00e1 vyl\u00e9\u010d\u00ed p\u0159es 40\u00a0procent pacient\u016f, kte\u0159\u00ed d\u0159\u00edve nem\u011bli \u0161anci.<\/p>\n

Hledaj\u00ed se nov\u00e9 l\u00e9ky ve v\u0161ech oblastech, ale st\u00e1le jsou diagn\u00f3zy, kde pr\u016flom nenastal a\u00a0\u010dek\u00e1me na nov\u00e9 mo\u017enosti. D\u016fle\u017eit\u00e9 je zd\u016fraznit optimismus\u00a0\u2013 onkologie se st\u00e1v\u00e1 optimistick\u00fdm oborem, proto\u017ee tam, kde d\u0159\u00edve t\u00e9m\u011b\u0159 nic ne\u0161lo, dnes m\u016f\u017eeme d\u011blat mo\u017en\u00e1 i\u00a0z\u00e1zraky.<\/p>\n","protected":false},"excerpt":{"rendered":"V\u00e1\u017en\u00e9 diagn\u00f3zy \u010dasto vy\u017eaduj\u00ed l\u00e9\u010dbu \u0161itou na m\u00edru. U\u00a0slo\u017eit\u00fdch \u010di vz\u00e1cn\u011bj\u0161\u00edch p\u0159\u00edpad\u016f ale \u00fahrada ze zdravotn\u00edho poji\u0161t\u011bn\u00ed neb\u00fdv\u00e1…\n","protected":false},"author":2,"featured_media":17007,"comment_status":"","ping_status":"","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[7],"tags":[43,42,41,40,2813,564,500,342],"class_list":{"0":"post-17006","1":"post","2":"type-post","3":"status-publish","4":"format-standard","5":"has-post-thumbnail","7":"category-cesko","8":"tag-ceska-republika","9":"tag-cesko","10":"tag-czech-republic","11":"tag-czechia","12":"tag-lecba","13":"tag-lekari","14":"tag-zdravotni-pojistovny","15":"tag-zdravotnictvi"},"share_on_mastodon":{"url":"https:\/\/pubeurope.com\/@cz\/116187526900407942","error":""},"_links":{"self":[{"href":"https:\/\/www.europesays.com\/cz\/wp-json\/wp\/v2\/posts\/17006","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.europesays.com\/cz\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.europesays.com\/cz\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.europesays.com\/cz\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/www.europesays.com\/cz\/wp-json\/wp\/v2\/comments?post=17006"}],"version-history":[{"count":0,"href":"https:\/\/www.europesays.com\/cz\/wp-json\/wp\/v2\/posts\/17006\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/www.europesays.com\/cz\/wp-json\/wp\/v2\/media\/17007"}],"wp:attachment":[{"href":"https:\/\/www.europesays.com\/cz\/wp-json\/wp\/v2\/media?parent=17006"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.europesays.com\/cz\/wp-json\/wp\/v2\/categories?post=17006"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.europesays.com\/cz\/wp-json\/wp\/v2\/tags?post=17006"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}